Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years | Zendy

Shida Yohei | Zendy; Hakariya Tomoaki | Zendy; Miyata Yasuyoshi | Zendy; Sakai Hideki | Zendy

Open Access

Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years

Author(s) -

Shida Yohei,

Hakariya Tomoaki,

Miyata Yasuyoshi,

Sakai Hideki

Publication year - 2017

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.854

Subject(s) - medicine , androgen deprivation therapy , prostate cancer , prostate , primary treatment , urology , androgen , cancer , oncology , gynecology , hormone

Key Clinical Message We report three cases of nonmetastatic prostate cancer treated effectively with long‐term primary intermittent androgen deprivation (IAD). IAD is not a standard therapy for patients with nonmetastatic prostate cancer. However, based on our experience, we suggest that IAD is one of useful therapeutic tools under certain patients’ condition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research